Apollon Formularies (AQSE:APOL) Gross Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Apollon Formularies's Gross Profit for the six months ended in Jun. 2023 was £0.05 Mil. Apollon Formularies's Revenue for the six months ended in Jun. 2023 was £0.05 Mil. Therefore, Apollon Formularies's Gross Margin % for the quarter that ended in Jun. 2023 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

The historical rank and industry rank for Apollon Formularies's Gross Margin % or its related term are showing as below:

During the past 11 years, the highest Gross Margin % of Apollon Formularies was 14.32%. The lowest was 2.95%. And the median was 8.97%.

AQSE:APOL's Gross Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 47.33
* Ranked among companies with meaningful Gross Margin % only.

Apollon Formularies had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Apollon Formularies was 0.00% per year.

Apollon Formularies Gross Margin % Historical Data

The historical data trend for Apollon Formularies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Gross Margin % Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Gross Margin %

Get a 7-Day Free Trial

8.97

2.95

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Gross Margin %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Gross Margin % falls into.

Apollon Formularies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Apollon Formularies's Gross Margin for the fiscal year that ended in Dec. 2021 is calculated as

Gross Margin % (A: Dec. 2021 )	=	Gross Profit (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	0.2	/	0.198
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.198 - 0)	/	0.198
	=	N/A %

Apollon Formularies's Gross Margin for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )	=	Gross Profit (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	0	/	0.048
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.048 - 0)	/	0.048
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Apollon Formularies (AQSE:APOL) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Apollon Formularies had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Apollon Formularies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.